Dacomitinib impurity 13
Dacomitinib impurity 13 is an impurity of Dacomitinib (HY-13272) .
Product Specifications
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Drug Intermediate
Related Pathways
Others
Field of Research
Others
Smiles
O=C(NC1=CC2=C(NC3=CC=C(Cl)C(Cl)=C3)N=CN=C2C=C1OC)/C=C/CN4CCCCC4
Molecular Formula
C24H25Cl2N5O2
Molecular Weight
486.39
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
Shipping Conditions
Room temperature
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
040966-AP 200 µL
RET, CT (T1078) (RET, CDHF12, CDHR16, PTC, RET51, Proto-oncogene tyrosine-protein kinase receptor Ret, Cadherin family member 12, Proto-oncogene c-Ret, Soluble RET kinase fragment, Extracellular cell-membrane anchored RET cadherin 120kD fragment) (AP) discontinued
Ask
View Details